Zacks Research Analysts Decrease Earnings Estimates for MRK
Merck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of Merck & Co., Inc. in a research note issued to investors on Tuesday, April 1st. Zacks Research analyst S. Ganoria now anticipates that the company will post earnings per share of $2.29 […]
